What is the recommendation for Antiplatelet and Anticoagulant Therapy during Percutaneous Coronary Intervention (PCI)?
Oral and Intravenous Antiplatelet Agents: It is recommended to administer a P2Y12 inhibitor as dual antiplatelet therapy with aspirin in patients undergoing PCI. GP IIb/IIIa Inhibitors: It is recommended to administer a GP IIb/IIIa inhibitor in patients with NSTE-ACS undergoing PCI with unfractionated heparin or bivalirudin.